Open Access Repository

Anti-inflammatories in Alzheimer's disease-potential therapy or spurious correlate?

Downloads

Downloads per month over past year

Rivers-Auty, J ORCID: 0000-0001-5321-2347, Mather, AE, Peters, R, Lawrence, CB and Brough, D 2020 , 'Anti-inflammatories in Alzheimer's disease-potential therapy or spurious correlate?' , Brain Communications, vol. 2, no. 2 , pp. 1-14 , doi: 10.1093/braincomms/fcaa109.

[img]
Preview
PDF
143283 - anti i...pdf | Download (530kB)

| Preview

Abstract

Epidemiological evidence suggests non-steroidal anti-inflammatory drugs reduce the risk of Alzheimer’s disease. However, clinical trials have found no evidence of non-steroidal anti-inflammatory drug efficacy. This incongruence may be due to the wrong non-steroidal anti-inflammatory drugs being tested in robust clinical trials or the epidemiological findings being caused by confounding factors. Therefore, this study used logistic regression and the innovative approach of negative binomial generalized linear mixed modelling to investigate both prevalence and cognitive decline, respectively, in the Alzheimer’s Disease Neuroimaging dataset for each commonly used non-steroidal anti-inflammatory drug and paracetamol. Use of most non-steroidal anti-inflammatories was associated with reduced Alzheimer’s disease prevalence yet no effect on cognitive decline was observed. Paracetamol had a similar effect on prevalence to these non-steroidal anti-inflammatory drugs suggesting this association is independent of the anti-inflammatory effects and that previous results may be due to spurious associations. Interestingly, diclofenac use was significantly associated with both reduce incidence and slower cognitive decline warranting further research into the potential therapeutic effects of diclofenac in Alzheimer’s disease.

Item Type: Article
Authors/Creators:Rivers-Auty, J and Mather, AE and Peters, R and Lawrence, CB and Brough, D
Keywords: Alzheimer’s disease, NSAID, anti-inflammatory, inflammation, progression
Journal or Publication Title: Brain Communications
Publisher: Oxford University Press
ISSN: 2632-1297
DOI / ID Number: 10.1093/braincomms/fcaa109
Copyright Information:

Copyright 2020 the author. Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/

Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP